Gene therapy’s success in dogs spurs hope about human trial

Deadly muscle-wasting disorder is target; testing to begin within months

KIRO-7 TV  |  Updated 10:15 AM, 05.22.2017

Posted in: Research

  • Nibs, top right, was first in the test colony of dogs with myotubular myopathy. UW Medicine

Within months, clinical trials of a gene therapy will begin with a small group of children affected with a deadly muscle-wasting disease.

Dr. Martin Childers, a UW Medicine researcher and physician, has led development of a therapy to address a form of muscular dystrophy called myotubular myopathy. Boys affected with the disease often die before age 2.

Dogs who have received injections of the genetic therapy have achieved remarkable results. Once destined to die, dogs show no signs of the disease after a single infusion of gene-replacement therapy. 

See the full story at KIRO-7 TV  

Tagged with: muscle disorders, gene therapy
Contact us about this story.